RECENT FUNDING
  1. Recent Funding
  2. Categories
  3. Health and bio

Health and bio

6,747 health and bio startups, $127.8B raised in sourced rounds, ranked by total raised.

Companies6,747
With a raise2,688
Raised$127.8B*
Raised mostVVerily$3B
About this page

6747 health and bio startups that have raised $127.8B in sourced rounds, ranked by total raised, with each one's first and latest raise.

The health and bio startup that has raised the most on Recent Funding is Verily, with $3B across 4 sourced rounds.

Health and bio startups ranked by total raised

#CompanyTotal raisedFirst raiseLater raise
1VVerily $3B
Series B+
· $300M
Series B+
2CCyera $2.7B · $60M
Series A
· $400M
Series B+
3DDevoted Health $2.27B · $62M
Series A
· $366M
Series B+
4ZZipline $1.57B · $190M
Series B+
· $200M
Series B+
5CCMR Surgical $1.41B · $242.09M
Series B+
· $400M
Series B+
6AAlan $1.39B · $28.3M
Series A
· $544.42M
Series B+
7OOura $1.24B · $5.3M
Series A
Series B+
8NNeko $1.02B · $65M
Series A
· $700M
Series B+
9OOpenEvidence $985M · $75M
Series A
· $250M
Series B+
10UUniphore $885.5M
Series A
Series B+
11LLambda $859M · $15M
Series A
Series B+
12EElement Biosciences $823M · $15M
Series A
· $175M
Series B+
13LLightmatter $800M · $11M
Series A
· $400M
Series B+
14WWHOOP $773M · $6M
Series A
· $575M
Series B+
15TTipalti $739M · $13M
Series B+
· $200M
round
16BBeeline Medicines $726.3M · $300M
Series A
· $426.3M
Series A
17EEnveda $714M · $68M
Series B+
· $311M
Series B+
18EEliseAI $710M · $35M
Series B+
· $350M
Series B+
19LLila Sciences $700M · $350M
Series A
· $350M
Series A
20SStrive Health $690M · $80M
Series A
· $300M
Series B+
21NNewLimit $650M · $40M
Series A
· $435M
Series B+
22MMirador Therapeutics $650M · $400M
Series A
· $250M
Series B+
23SSolugen $643.4M · $4.4M
seed
· $50M
Series B+
24MMedable $633M · $25M
Series A
· $304M
Series B+
25SSynchron $600M · $10M
Series A
· $275M
Series B+
26TTonal $580M · $3M
seed
· $130M
round
27VVulcanForms $575M · $355M
Series B+
· $220M
Series B+
28TTubulis $573M · $12M
Series A
· $360M
Series B+
29LLifeMine Therapeutics $543M · $55M
Series A
· $188M
Series B+
30GGong $541M · $6M
seed
Series B+
31VVarda $528M · $90M
Series B+
· $251M
Series B+
32SSkyryse $513M · $13M
Series B+
· $300M
Series B+
33SSiMa AI $495M · $30M
Series A
· $150M
Series B+
34EExein $494.12M · $2.28M
seed
· $270M
Series B+
35AAbcuro $463M
Series A
· $66M
Series B+
36TTreeline Biosciences $461M · $261M
Series A
· $200M
Series A
37SSynthego $459M · $8M
Series A
· $200M
Series B+
38BBiofourmis $456M · $1M
pre seed
· $20M
Series B+
39OOrca Bio $442M · $192M
Series B+
Series B+
40AAdvanCell $439.5M · $12.5M
Series B+
· $315M
Series B+
41HHorizon3.ai $428.5M · $8.5M
Series A
· $250M
Series B+
42AAcko $426M · $30M
seed
· $255M
Series B+
43OOMass Therapeutics $422.51M
Series A
· $310M
Series B+
44DDren Bio $415M
Series A
· $350M
round
45SStar Therapeutics $415M · $90M
Series B+
· $200M
Series B+
46TTorl Bio $412M · $158M
Series B+
· $96M
Series B+
47VVerdiva Bio $410M · $410M
Series A
—
48PPlenty $405M · $400M
Series B+
· $5M
seed
49DDistalmotion $390M
Series A
· $150M
Series B+
50HHippocratic AI $385M · $50M
seed
· $126M
Series B+
51TTranscarent $384M · $58M
Series B+
· $126M
Series B+
52CColossal $380M · $60M
Series A
· $120M
Series B+
53AAidoc $373M · $27M
Series B+
· $150M
Series B+
54FFormation Bio $372M · $372M
Series B+
—
55HHostaway $365M
seed
· $365M
round
56UUmoja Biopharma $363M · $53M
Series A
· $100M
Series B+
57MMusely $360M
Series B+
· $360M
round
58TTalkiatry $360M · $20M
Series A
· $210M
Series B+
59CCellares $357M · $18M
Series A
Series B+
60FFunction Health $351M · $53M
Series A
· $298M
Series B+
61CCellCentric $340M · $120M
Series B+
· $220M
Series B+
62AAspen Neuroscience $339M · $6.5M
seed
· $115M
Series B+
63SSoufflé Therapeutics $335M · $200M
Series A
· $135M
Series B+
64HHalter $334M · $29M
Series B+
Series B+
65GGrow Therapy $328M · $15M
Series A
· $150M
Series B+
66MMMI $310M · $75M
Series B+
· $125M
Series B+
67PPrecision Neuroscience $303M · $12M
Series A
· $250M
Series B+
68BBlueground $302M · $2M
seed
· $45M
Series B+
69HHeadway $295M · $70M
Series B+
· $100M
Series B+
70IImmunai $295M · $20M
seed
· $215M
Series B+
71AAmolyt Pharma $294M · $74M
Series A
· $140M
Series B+
72SSynthekine $290M · $82M
Series A
· $100M
Series B+
73AArbor Biotechnologies $289M · $215M
Series B+
· $74M
Series B+
74AAltruBio $288M · $63M
Series A
· $225M
Series B+
75AAiralo $285.4M · $5.4M
Series A
· $220M
Series B+
76EEmalex Biosciences $285M · $35M
Series B+
· $250M
Series B+
77TT-Therapeutics $283M · $59M
Series A
· $133M
Series B+
78EEight Sleep $276M · $40M
Series B+
· $50M
round
79DDexory $275.31M · $19M
Series A
· $11.31M
Series B+
80AAbnormal Security $274M · $24M
Series A
Series B+
81SScandit $273.5M · $5.5M
pre seed
· $150M
Series B+
82SStaffbase $272.25M · $2.25M
Series A
· $115M
Series B+
83AA2 Biotherapeutics $270.5M · $57M
Series A
· $80M
Series B+
84OOrbital Therapeutics $270M · $270M
Series A
Series A
85NNouscom $267.56M · $13.58M
Series A
· $135.04M
Series B+
86GGarner Health $263M · $45M
Series B+
· $100M
Series B+
87CCardurion Pharmaceuticals $260M · $260M
Series B+
—
88CCatalYm $259.04M · $59.04M
Series B+
· $150M
Series B+
89AAcepodia $256M · $47M
Series B+
· $100M
Series B+
90CCanary Technologies $255M · $15M
Series A
· $80M
Series B+
91MMatchpoint Therapeutics $250M · $100M
Series A
· $150M
Series B+
92FForge Biologics $250M · $40M
Series A
· $90M
Series B+
93MMidi Health $249M · $14M
seed
· $100M
Series B+
94HHuma Therapeutics $248M · $130M
Series B+
· $38M
round
95AARTBIO $245M · $23M
seed
· $132M
Series B+
96AAiolos Bio $245M · $245M
Series A
—
97SShiftMed $245M · $45M
Series B+
· $200M
round
98CCloudbeds $244M · $3M
Series A
· $150M
Series B+
99IIDRx $242M · $122M
Series A
· $120M
Series B+
100VViz.ai $242M · $21M
Series A
· $100M
Series B+
101TTissium $241.14M · $25M
Series A
· $60M
Series B+
102PPathos $237M · $237M
Series B+
—
103MMOMA Therapeutics $236M · $86M
Series A
· $150M
Series B+
104FFrontier Medicines $235.5M · $67M
Series A
Series B+
105TTenpoint Therapeutics $235M · $235M
Series B+
Series A
106OOricell Therapeutics $235M · $120M
Series B+
round
107CCity Therapeutics $234.5M · $135M
Series A
Series B+
108CChai Discovery $230M · $30M
seed
round
109SScience $230M · $230M
Series B+
—
110AArthrosi Therapeutics $228M · $75M
Series B+
· $153M
Series B+
111AApollo Therapeutics $226.5M · $226.5M
Series B+
—
112DDomino Data Lab $223.5M · $3M
Series A
Series B+
113EEngrail Therapeutics $221M · $32M
Series A
· $157M
Series B+
114AAtavistik Bio $220M · $60M
Series A
· $40M
Series B+
115PPapa $220M · $10M
Series A
Series B+
116EElemy $219M · $219M
Series B+
—
117AAsher Bio $218M · $55M
Series A
· $55M
Series B+
118TThird Arc Bio $217M · $165M
Series A
· $52M
Series A
119IImmuta $217M · $7M
Series A
Series B+
120GGeneoscopy $216.9M · $6.9M
Series A
· $105M
Series B+
121WWarp Sciences $215M · $215M
Series A
—
122TTune Therapeutics $215M · $40M
Series A
· $175M
Series B+
123HHI-Bio $215M · $120M
Series A
· $95M
Series B+
124BBiolinq $214.75M · $10M
Series A
· $100M
Series B+
125WWheel $213.9M · $13.9M
Series A
Series B+
126IImmune-Onc Therapeutics $211M · $7M
Series A
· $131M
Series B+
127HHotSpot Therapeutics $210M · $45M
Series A
· $100M
Series B+
128CChapter $209M · $17M
Series A
· $100M
Series B+
129JJnana Therapeutics $207M · $50M
Series A
· $107M
Series B+
130YYuLife $207M · $4M
seed
· $120M
Series B+
131IInspiren $205M · $35M
Series A
· $70M
Series B+
132DDraig Therapeutics $205M · $140M
seed
· $65M
Series B+
133PPearl Health $203M · $18M
Series A
· $110M
Series B+
134VVerana Health $202M · $150M
Series B+
Series B+
135AAmber Therapeutics $200M · $100M
Series A
· $100M
Series A
136WWindward Bio $200M · $200M
Series A
round
137AAirNexis Therapeutics $200M · $200M
Series A
—
138SSironax $200M · $200M
Series B+
Series B+
139WWhen I Work $200M · $200M
Series B+
—
140NNeuron23 $197M · $100M
Series B+
· $97M
Series B+
141SSplice Bio $197M · $57M
Series A
· $140M
Series B+
142LLaza Medical $196M · $36M
Series A
· $160M
Series B+
143AAngle Health $196M · $4M
seed
Series B+
144GGlycomine $195M · $12M
Series A
· $115M
Series B+
145LLiquid Death $194M · $2M
seed
seed
146CCentivo $194M · $34M
Series A
· $75M
round
147NNEURA Robotics $192M · $56M
Series A
Series B+
148PPrenuvo $190M · $70M
Series A
Series B+
149ZZoovu $188M · $5M
Series A
· $169M
Series B+
150TT-Knife $188M · $78M
Series A
· $110M
Series B+
151TThatch $186M · $38M
Series A
· $108M
Series B+
152HHealthKart $185.99M · $14M
Series B+
· $135M
Series B+
153AAvantStay $185M · $5M
seed
Series B+
154QQventus $185M · $30M
Series B+
· $105M
Series B+
155FFore Biotherapeutics $182.4M · $75M
Series B+
· $67.4M
Series B+
156NNexHealth $181.5M · $1.5M
seed
· $130M
Series B+
157MMediar Therapeutics $181M · $105M
Series A
· $76M
Series B+
158CCelea Therapeutics $180M · $180M
Series A
—
159LLogicSource $180M · $180M
Series B+
—
160GGlycoEra $179M · $49M
Series A
· $130M
Series B+
161AAccent Therapeutics $178M · $40M
Series A
· $75M
Series B+
162AAzafaros $177M · $27M
Series A
· $150M
Series B+
163CClaris Bio $175M · $57M
Series A
· $118M
Series B+
164HHealthifyMe $175M · $6M
Series A
· $45M
Series B+
165AAlpha-9 Oncology $175M · $175M
Series B+
—
166MMariana Oncology $175M · $175M
Series B+
—
167PPulmocide $174.4M · $30.4M
Series B+
· $52M
Series B+
168CCandid Health $172.5M
Series B+
· $120M
Series B+
169NNoema Pharma $171M · $59M
Series A
Series B+
170AAtomwise $171M · $6M
seed
Series B+
171EEnvoy $171M · $15M
Series A
· $110M
Series B+
172SStedi $170M · $50M
Series B+
· $50M
Series B+
173FFlare Therapeutics $167M · $82M
Series A
· $85M
Series B+
174LLoyal $167M · $45M
Series B+
Series A
175VVedanta Biosciences $166.5M
Series B+
· $60M
round
176BBionyra $165M · $165M
Series A
—
177SSyremis Therapeutics $165M · $165M
Series A
—
178EExcelsior Sciences $165M · $95M
round
· $70M
Series A
179EEverside Health $164M · $164M
round
—
180BBeewise $162M · $10M
Series A
· $50M
Series B+
181PPlate IQ $160M · $160M
Series B+
—
182TTandem Health $159.5M · $9.5M
seed
· $100M
Series B+
183AAblative Solutions $159.3M · $5.3M
Series A
· $77M
Series B+
184AAKUR8 $158.9M · $8.9M
Series A
· $120M
Series B+
185RR1 Therapeutics $158M · $77.5M
Series A
· $80.5M
Series A
186EEpicrispr Biotechnologies $158M · $68M
Series B+
· $90M
Series B+
187CCrossbow Therapeutics $157M · $80M
Series A
· $77M
Series B+
188BBiossil $156.7M · $3.7M
seed
· $153M
round
189TTennr $156.5M* · $18M
Series A
Series B+
190TTrialSpark $156M · $156M
Series B+
—
191IImpress $155.89M · $5.89M
seed
· $100M
Series B+
192UUltrahuman $155.82M · $17.5M
Series B+
· $60M
Series B+
193TTruemeds $155.11M · $5M
Series A
· $85M
round
194QQualified Health $155M · $30M
seed
· $125M
Series B+
195RRad AI $155M · $4M
seed
· $8M
Series B+
196AAnaveon $155M · $35M
Series A
· $120M
Series B+
197AAntheia $153M · $73M
Series B+
· $24M
Series B+
198VVaderis Therapeutics $152M · $152M
Series B+
—
199AAlteogen $150M · $150M
Series B+
—
200CCohere Health $150M · $10M
Series A
Series B+
201ZZarminali Pediatrics $150M · $40M
seed
· $110M
Series A
202CCurative $150M · $150M
Series B+
—
203AAlleviate $150M · $150M
Series B+
—
204CCognigy $150M · $6M
Series A
· $100M
Series B+
205CClinChoice $150M · $150M
Series B+
—
206HHonest Kitchen $150M · $150M
round
—
207CCardiac Dimensions $149.2M · $20M
Series A
· $53M
Series B+
208SStanza Living $146.19M · $2M
seed
· $32.19M
Series B+
209SStash Global $146M · $146M
Series B+
—
210LLuma Health $146M
Series A
· $130M
Series B+
211SSuki Redwood City $145M · $20M
Series B+
Series B+
212KKinaset Therapeutics $143M · $40M
Series A
· $103M
Series B+
213LLumafield $142.5M · $32.5M
seed
· $75M
Series B+
214NNura Bio $141.8M · $68M
Series A
· $73.8M
Series B+
215AAugmedics $141.8M · $8.3M
Series A
· $82.5M
Series B+
216HHarbinger Health $140M · $140M
Series B+
round
217HHonest Health $140M · $140M
round
—
218IImpulse Dynamics $140M · $80M
Series B+
round
219NNormunity $140M · $65M
Series A
· $75M
Series B+
220UUroMems $139.67M · $15.07M
Series A
· $60M
round
221EEndogenex $138M · $88M
Series B+
· $50M
Series B+
222CClass Technologies $138M · $16M
seed
seed
223IInstawork $138M · $18M
Series B+
· $60M
Series B+
224EEndovascular Engineering $137M · $15M
Series A
· $80M
Series B+
225EEasyHealth $135M · $135M
Series A
—
226EEko Health $133.8M · $800K
seed
Series B+
227AAngitia Bio $130M
Series B+
· $130M
Series B+
228SSolace Health $130M · $130M
Series B+
—
229PProtego $130M · $130M
Series B+
—
230BBig Health $129.3M · $3.3M
Series A
· $75M
Series B+
231LLyka $129M · $500K
pre seed
· $67M
Series B+
232CCalibrate $128M · $5M
seed
Series B+
233SStrata Oncology $128M · $12M
Series A
· $90M
Series B+
234KKasa Living $126M · $6M
seed
Series B+
235BBright Peak Therapeutics $125M · $35M
Series A
Series B+
236SSonoThera $125M · $125M
Series B+
—
237CCollate $125M · $30M
seed
· $95M
Series A
238CCoultreon $125M · $125M
Series A
—
239AAmbros Therapeutics $125M · $125M
Series A
—
240EEverlab $124M · $3M
pre seed
seed
241CCartography Biosciences $124M · $57M
Series A
· $67M
Series B+
242PPersonal Genome Diagnostics $123.8M · $2.8M
pre seed
Series B+
243TTasso $123.1M · $6.1M
Series A
· $100M
Series B+
244BBolt Threads $123M · $123M
Series B+
Series B+
245IIVX Health $123M · $23M
Series B+
· $100M
Series B+
246FFineHeart $122.43M · $7.19M
Series A
· $96.9M
Series B+
247AAnsa Biotechnologies $122.4M · $68M
Series A
· $54.4M
Series B+
248AActio Biosciences $121M · $55M
Series A
· $66M
Series B+
249OOrbis Medicines $121M · $28M
seed
· $93M
Series A
250CCellarity $121M · $121M
Series B+
Series B+
How this is counted

The top 250 of 6,747. All of them, as JSON: /api/v1/categories/health-bio.

Total raised sums the rounds that link to a source; each amount links to it. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. "First raise" is the earliest dated round on record, which may be later than the company's real first raise while raise histories are being filled in; "—" means that is still the only round we have. API: /api/v1/categories/health-bio?sort=raised.

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy